1 800 FLOWERS COM INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data 1 800 FLOWERS COM INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	1,194	1,152	1,249	1,490	2,122	2,208	2,018	1,831	1,686	1,504
Cost of revenue	673	663	723	867	1,226	1,386	1,260	1,097	1,033	932
Gross profit	520	489	526	622	896	822	758	735	652	571
Selling and marketing	318	299	320	363	533	572	501	485	480	403
General and administrative	84.1	77.4	87.7	97.4	117	102	113	118	117	139
Operating expenses	474	448	481	542	747	780	793	737	857	698
Operating income	46.4	41	45.1	80.4	149	42.1	-35	-2.07	-205	-127
Interest expense							14.1	17.3	15.4	17
Interest income							3.1	6.68	3.38	1.86
Other non-operating income	15.5	0.61	0.64	-0.08	5.89	-5.33	-0.81	6.79	3.51	7.45
Pre-tax income	56	38	43	77.8	149
Income tax	12	-2.77	8.22	18.8	30.5	1.49	-2.06	0.2	-13.4	-0
Income from continuing operations	44	40.8
Net income	44	40.8	34.8	59	119	29.6	-44.7	-6.11	-200	-135
EBITDA	79.7	73.5	75.1	113	192	91.2	18.7	51.7	-151	-73.5
EPS, basic	0.68	0.63	0.54	0.92	1.83	0.46	-0.69	-0.09	-3.13	-2.11
EPS, diluted	0.65	0.61	0.52	0.89	1.78	0.45	-0.69	-0.09	-3.13	-2.11
Shares, basic (weighted)	65.2	64.7	64.3	64.5	64.7	65	64.7	64.6	63.8	63.9
Shares, diluted (weighted)	67.7	66.9	66.5	66.4	66.5	65.6	64.7	64.6	63.8	63.9

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	150	147	173	241	174	31.5	127	159	46.5	11.4
Receivables	14.1	12.9	12.4	15.2	20.8	23.8	20.4	18	21.7	21.6
Inventory	75.9	88.8	92.4	97.8	154	248	191	177	177	153
Other current assets	17.7	24	25.6	25.2	51.8	45.4	34.6	31.7	37.4	25.7
Total current assets	257	273	303	379	400	348	373	386	283	211
Property, plant and equipment	161	163	167	169	215	236	235	224	216	194
Lease right-of-use assets				66.8	86.2	129	125	114	107	103
Goodwill	62.6	62.6	62.6	74.7	208	213	153	157	37.6	3.07
Intangible assets	61.1	59.8	59.6	66.3	139	146	140	116	89.4	77.4
Other non-current assets	10	12.1	14.3	19	27.9	21.9	25.7	36.4	39.8	47.9
Total assets	552	571	606	774	1,077	1,095	1,051	1,033	773	637
Accounts payable	27.8	41.4	25.7	25.3	57.4	57.4	52.6	80	74.6	69
Accrued liabilities	90.2	73.3	96.8	142	179	175	142	121	110	119
Deferred revenue	13.9	13.5	17.3	25.9	33.4	33.7	30.8	25	23.7	19.5
Short-term debt	7.19	10.1	5	5	20	20	10	10	21	24
Total current liabilities	125	125	127	180	266	266	220	228	221	229
Long-term debt	101	92.3	92	87.6	162	142	186	177	135	112
Lease liabilities				62	79.4	124	117	106	99.6	95.5
Other non-current liabilities	9.81	12.7	15.4	16.2	26.6	17.9	24.5	36.1	41.9	50.5
Total liabilities	270	256	264	375	568	585	580	566	504	493
Total debt	109	102	97	92.6	182	162	196	187	156	136
Paid-in capital	338	342	349	358	371	380	388	399	411	423
Retained earnings	32.6	73.4	109	168	286	316	271	265	65	-69.8
Treasury stock	-88.8	-101	-116	-126	-149	-187	-188	-199	-209	-210
Other comprehensive income	-0.19	-0.2	-0.27	-0.24	-0.32	-0.21	-0.17	-0.13	-0.14	-0.1
Shareholders' equity	282	315	343	400	509	509	472	466	268	144
Total equity	282	315	343	400	509	509	472	466	268	144
Total liabilities and equity	552	571	606	774	1,077	1,095	1,051	1,033	773	637

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	44	40.8	34.8	59	119	29.6	-44.7	-6.11	-200	-135
Depreciation and amortization	33.4	32.5	30	32.5	42.5	49.1	53.7	53.8	53.6	53.6
Stock-based compensation	6.1	3.73	6.31	8.43	10.8	7.95	8.33	10.7	11.9	11.3
Deferred income tax	-1.65	-7.67	2.7	-0.27	5.53	1.58	-4.61	-11.7	-12.7	-0.69
Change in receivables	-6.22	0.07	-0.82	-6.95	-5.24	-2.45	-0.6	2.14	-4.28	3.55
Change in inventory	-9.28	-13	-3.54	-4.37	-39.1	-85	57.6	14.6	0.76	24.3
Change in payables	9.13	5.25	8.85	44.4	57.4	-6.6	-38.6	6.4	-17	-0.2
Cash from operations	61	58.3	78.1	139	173	5.19	115	95	-26.4	18.3
Capital expenditures	-33.7	-33.3	-32.6	-34.7	-55.2	-66.4	-44.6	-38.6	-41.5	-31.3
Acquisitions			0	-20.5	-251	-21.3	-6.15	-3.67	-3	0
Cash from investing	78.3	-41.8	-32.6	-56.4	-308	-89.7	-50.8	-42.3	-44.5	-31.3
Debt repaid	-186	-37.2	-37.2	-25	-175	-145	-361	-92	-140	-196
Stock issued	0.29	0.34	1.24	0.29	2.25	0.85	0	0.33	0.28	0
Share buybacks	-10.7	-12.2	-14.8	-10.7	-22.4	-38.2	-1.24	-10.4	-10.2	-1.16
Cash from financing	-17.4	-19	-19.9	-15.5	67.7	-57.6	30.8	-20.1	-42.1	-22.2
Net change in cash	122	-2.49	25.7	67.6	-66.9	-142	95.3	32.6	-113	-35.1
Free cash flow	27.4	25	45.5	105	118	-61.2	70.7	56.4	-67.8	-13
Interest paid	4.4	4	4.7	3.5	5.2	4.6	12.8	16.3	14.4	15.9
Income taxes paid	6.8	5.2	8.8	15.5	37.2	1.4	-8.8	8	1.6	-2.58

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $2.68 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	38.0%	Gross profit / revenue.
Operating margin	-8.5%	Operating income / revenue.
EBITDA margin	-4.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	-9.0%	Net income / revenue.
FCF margin	-0.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	1.2%	Cash from operations / revenue.
Return on equity (ROE)	-65.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-19.1%	Net income / average total assets.
Return on invested capital (ROIC)	-31.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.1%	Capital expenditures / revenue.
D&A / revenue	3.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-10.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-9.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-6.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-12.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-9.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-8.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y	-45.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-36.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-46.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-32.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-22.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-17.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-15.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-10.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.92x	Current assets / current liabilities.
Quick ratio	0.14x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.05x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.95x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	21.4%	Total debt / total assets.
Liabilities / assets	77.4%	Total liabilities / total assets.
Net debt	$124.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-7.50x	Operating income / interest expense.
Working capital	-$17.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	12.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$63.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.13x	Revenue / average total assets.
Fixed asset turnover	7.34x	Revenue / average property, plant and equipment.
Inventory turnover	5.65x	Cost of revenue / average inventory.
Days inventory	65 days	365 x average inventory / cost of revenue.
Receivables turnover	69.5x	Revenue / average receivables.
Days sales outstanding	5 days	365 x average receivables / revenue.
Days payables	28 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	42 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	170.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$2.11	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$2.11	Net income per basic share, as reported (split-adjusted).
Revenue per share	$23.52	Revenue / diluted weighted shares.
FCF per share	-$0.20	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.29	Cash from operations / diluted weighted shares.
Book value per share	$2.25	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.99	Tangible book value / shares outstanding.
Cash per share	$0.18	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$171.8M	Share price x shares outstanding.
Enterprise value	$296.6M	Market cap + total debt - cash - short-term investments.
P/S	0.11x	Market cap / revenue.
P/B	1.20x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.72x	Market cap / tangible book value, when positive.
P/OCF	9.38x	Market cap / cash from operations, when positive.
EV/Sales	0.20x	Enterprise value / revenue.
FCF yield	-7.6%	Free cash flow / market cap.
Earnings yield	-78.5%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.7%	(Dividends paid + share buybacks) / market cap.

What was 1 800 FLOWERS COM INC's revenue in fiscal 2026?

1 800 FLOWERS COM INC reported revenue of $1.50B for fiscal 2026, 10.8% lower than the year before.

Was 1 800 FLOWERS COM INC profitable in fiscal 2026?

No. It reported a net loss of $134.8M.

How much free cash flow did 1 800 FLOWERS COM INC generate in fiscal 2026?

Cash from operations of $18.3M minus capital expenditures of $31.3M left free cash flow of -$13.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to 1 800 FLOWERS COM INC